Medical marijuana is proliferating across the country due to the ability of cannabis ingestion to treat important clinical problems such as chronic pain. However, negative side effects and the development of tolerance limit the widespread therapeutic use of Δ9-tetrahydrocannabinol (Δ9-THC), the major neurological ingredient in cannabis. THC’s side effects are produced via its actions at cannabinoid CB1 receptors in the brain. Thus, the medical community … Continue reading Cannabinoid CB2 receptors suppress neuropathic pain with no signs of physical dependence in study.